|
1
|
Feng Y and Walsh CA: The many faces of
filamin: A versatile molecular scaffold for cell motility and
signalling. Nat Cell Biol. 6:1034–1038. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Popowicz GM, Schleicher M, Noegel AA and
Holak TA: Filamins: Promiscuous organizers of the cytoskeleton.
Trends Biochem Sci. 31:411–419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meng X, Yuan Y, Maestas A and Shen Z:
Recovery from DNA damage-induced G2 arrest requires actin-binding
protein filamin-A/actin-binding protein 280. J Biol Chem.
279:6098–6105. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duval D, Lardeux A, Le Tourneau T, Norris
RA, Markwald RR, Sauzeau V, Probst V, Le Marec H, Levine R, Schott
JJ and Merot J: Valvular dystrophy associated filamin A mutations
reveal a new role of its first repeats in small-GTPase regulation.
Biochim Biophys Acta. 1843:234–244. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakamura F, Pudas R, Heikkinen O, Permi P,
Kilpeläinen I, Munday AD, Hartwig JH, Stossel TP and Ylänne J: The
structure of the GPIb-filamin A complex. Blood. 107:1925–3192.
2016. View Article : Google Scholar
|
|
6
|
Shao QQ, Zhang TP, Zhao WJ, Liu ZW, You L,
Zhou L, Guo JC and Zhao YP: Filamin A: Insights into its exact role
in cancers. Pathol Oncol Res. 22:245–252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yue J, Lu H, Liu J, Berwick M and Shen Z:
Filamin-A as a marker and target for DNA damage based cancer
therapy. DNA Repair (Amst). 11:192–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Savoy RM and Ghosh PM: The dual role of
filamin A in cancer: Can't live with (too much of) it, can't live
without it. Endocr Relat Cancer. 20:R341–R356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ford D, Easton DF, Bishop DT, Narod SA and
Goldgar DE: Risks of cancer in BRCA1-mutation carriers. Breast
cancer linkage consortium. Lancet. 343:692–695. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Easton DF, Bishop DT, Ford D and Crockford
GP: Genetic linkage analysis in familial breast and ovarian cancer:
Results from 214 families. The breast cancer linkage consortium. Am
J Hum Genet. 52:678–701. 1993.PubMed/NCBI
|
|
11
|
Gowen LC, Johnson BL, Latour AM, Sulik KK
and Koller BH: Brca1 deficiency results in early embryonic
lethality characterized by neuroepithelial abnormalities. Nat
Genet. 12:191–194. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Velkova A, Carvalho MA, Johnson JO,
Tavtigian SV and Monteiro AN: Identification of Filamin A as a
BRCA1-interacting protein required for efficient DNA repair. Cell
Cycle. 9:1421–1433. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Benson DA, Karsch-Mizrachi I, Lipman DJ,
Ostell J and Wheeler DL: GenBank. Nucleic Acids Res. 33:D34–D38.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hartwig JH and Stossel TP: Isolation and
properties of actin, myosin, and a new actinbinding protein in
rabbit alveolar macrophages. J Biol Chem. 250:5696–5705.
1975.PubMed/NCBI
|
|
16
|
Nakamura F, Stossel TP and Hartwig JH: The
filamins: Organizers of cell structure and function. Cell Adh Migr.
5:160–169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Flanagan LA, Chou J, Falet H, Neujahr R,
Hartwig JH and Stossel TP: Filamin A the Arp2/3 complex, and the
morphology and function of cortical actin filaments in human
melanoma cells. J Cell Biol. 155:511–517. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ai J, Huang H, Lv X, Tang Z, Chen M, Chen
T, Duan W, Sun H, Li Q, Tan R, et al: FLNA and PGK1 are two
potential markers for progression in hepatocellular carcinoma. Cell
Physiol Biochem. 27:207–216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin JF, Xu J, Tian HY, Gao X, Chen QX, Gu
Q, Xu GJ, Song JD and Zhao FK: Identification of candidate prostate
cancer biomarkers in prostate needle biopsy specimens using
proteomic analysis. Int J Cancer. 121:2596–2605. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang X, Yue J, Lu H, Campbell N, Yang Q,
Lan S, Haffty BG, Yuan C and Shen Z: Inhibition of filamin-A
reduces cancer metastatic potential. Int J Biol Sci. 9:67–77. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alper O, Stetler-Stevenson WG, Harris LN,
Leitner WW, Ozdemirli M, Hartmann D, Raffeld M, Abu-Asab M, Byers
S, Zhuang Z, et al: Novel anti-filamin-A antibody detects a
secreted variant of filamin-A in plasma from patients with breast
carcinoma and high-grade astrocytoma. Cancer Sci. 100:1748–1756.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tian HM, Liu XH, Han W, Zhao LL, Yuan B
and Yuan CJ: Differential expression of filamin A and its clinical
significance in breast cancer. Oncol Lett. 6:681–686. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miki Y, Swensen J, Shattuck-Eidens D,
Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM
and Ding W: A strong candidate for the breast and ovarian cancer
susceptibility gene BRCA1. Science. 266:66–71. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim KM, Moon YJ, Park SH, Park HJ, Wang
SI, Park HS, Lee H, Kwon KS, Moon WS, Lee DG, et al: Individual and
combined expression of DNA damage response molecules PARP1,
gammaH2AX, BRCA1, and BRCA2 predict shorter survival of soft tissue
sarcoma patients. PLoS One. 11:e01631932016. View Article : Google Scholar : PubMed/NCBI
|
